中韩高清无砖专区2022

中韩高清无砖专区2022 > 创新研发 > 临床试验

创新研发管线我们的科学临床试验平台合作者

临床试验

Clinical trial

Study Title	Conditions	Interventions	Locations
A Study of HSK29116 in Adults With Relapsed/Refractory B-cell Malignancies2	Relapsed/Refractory B-Cell Malignancies	Drug: HSK29116	One Clinical Research Perth, Australia Woden Dermatology Phillip, Australia NANFANG Hospital Guangzhou, Guangdong, China (and 3 more...)

中韩高清无砖专区2022-免费中韩高清无专码区-中韩高清无专樱桃砖区2021

<tfoot id='tqiGL'></tfoot>

<legend id='tpC3KqT'><style id='Qpqo'><dir id='SZHzJ'><q id='6EgCq0'></q></dir></style></legend>

<i id='Zg7go'><tr id='tbYvF'><dt id='cNv0O'><q id='KWEbk'><span id='EHIaj'><b id='qULy'><form id='8fehN'><ins id='ipl6'></ins><ul id='96lML'></ul><sub id='idLXhn7'></sub></form><legend id='oNtL'></legend><bdo id='sZrf'><pre id='1kKkpO1'><center id='KLZ1'></center></pre></bdo></b><th id='T9JO9'></th></span></q></dt></tr></i><div id='DUvVMZWF'><tfoot id='70orq'></tfoot><dl id='VaNhA'><fieldset id='6Bd2P'></fieldset></dl></div>

<sup id='R1cQQMbg'><pre id='toaVKE'></pre></sup><em id='W8UX'></em>

<li id='Y31ivp'><abbr id='XaivdUU'></abbr></li>